RESUMEN
INTRODUCTION: The aim of the present study was to determine the demographic, epidemiological and clinical characteristics of adult patients with tetanus in Slovenia between 2006 and 2021, as well as to determine the therapeutic approaches which have been successfully used in the intensive care unit (ICU) of the Infectious Diseases Department in the University Medical Centre Ljubljana (UMC). METHODS: We included all adult patients who were treated for tetanus in the ICU of the Department of Infectious Diseases Ljubljana between January 1st, 2006, and December 31th, 2021, in the retrospective study. Available epidemiological and clinical characteristics were reviewed from the medical documentation. RESULTS: There were 31 patients included in the study, four (12.9%) males and 27 (87.1%) females. The vast majority of patients required mechanical ventilation (MV) (87.1%) which lasted (±â¯SD) on average 35.4⯱â¯16.0 days. Autonomic dysfunction was present in 29 (93.5%) patients and was statistically significantly associated with shorter disease evolution (pâ¯=â¯0.005) and presence of healthcare-associated infection (pâ¯=â¯0.020). During the hospitalization, 27 (87.1%) patients acquired at least one healthcare-associated infection, most commonly ventilator-associated pneumonia. The average length of stay in the ICU (±â¯SD) was 42.5⯱â¯21.3 days. With increasing age, MV lasted statistically significantly longer (pâ¯=â¯0.001), length of stay was longer (pâ¯=â¯0.015), and healthcare-associated infections occurred (pâ¯=â¯0.003) more frequently. Four patients (12.9%) died. CONCLUSIONS: Although the tetanus incidence rate in Slovenia is high in comparison to other European countries on average, our therapeutic approach resulted in a good survival rate and low mortality.
Asunto(s)
Enfermedades Transmisibles , Tétanos , Masculino , Femenino , Humanos , Adulto , Estudios de Cohortes , Estudios Retrospectivos , Tétanos/epidemiología , Tétanos/terapia , Eslovenia/epidemiología , Respiración Artificial , Unidades de Cuidados Intensivos , Tiempo de InternaciónRESUMEN
The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-19. Apart from respiratory failure, COVID-19 may be associated with various autoimmune complications. We present a case of a critically ill patient with COVID-19 who developed severe immune thrombocytopenia that was successfully treated with a concomitant use of corticosteroids and intravenous immunoglobulins.
Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/complicaciones , Neumonía Viral/complicaciones , Púrpura Trombocitopénica Idiopática/etiología , COVID-19 , Enfermedad Crítica , Humanos , Masculino , Persona de Mediana Edad , Pandemias , Transfusión de Plaquetas , Púrpura Trombocitopénica Idiopática/terapia , SARS-CoV-2RESUMEN
Five patients in a geropsychiatric unit of a psychiatric hospital became abruptly ill with pneumonia caused by Streptococcus pneumoniae serotype 6A. Four other residents were colonized with the same serotype, which has previously not been reported in association with pneumonia outbreaks. Furthermore, serotype 6A is not included in all vaccine types, which may be important for the choice of vaccine in some settings. All isolates showed identical pulsed-field gel electrophoresis restriction patterns.